Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$11.03 -0.19 (-1.69%)
As of: Oct 22, 2026 · 2:43 PM EDT

Monte Rosa Therapeutics (GLUE) Ending Cash Balance (2020 - 2026)

Updated

Analysis

Monte Rosa Therapeutics (GLUE) Ending Cash Balance (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,166.05 Bn 1,134.64 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 647.70 Bn 567.56 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.26 Bn 476.37 Bn 12.70 Bn 6.57 Bn
4 Merck 366.29 Bn 320.67 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 268.96 Bn 242.64 Bn 12.86 Bn 4.88 Bn
7 Amgen 242.14 Bn 197.54 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.83 Bn 169.02 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn 1.03 Bn
10 Monte Rosa Therapeutics 1.12 Bn 532.14 Mn - 95.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 95.04 Mn
Mar 31, 2026 164.81 Mn
Dec 31, 2025 134.84 Mn
Sep 30, 2025 213.29 Mn
Jun 30, 2025 74.38 Mn
Mar 31, 2025 83.41 Mn
Dec 31, 2024 229.12 Mn
Sep 30, 2024 130.48 Mn
Jun 30, 2024 113.71 Mn
Mar 31, 2024 104.62 Mn
Dec 31, 2023 132.68 Mn
Sep 30, 2023 63.58 Mn
Jun 30, 2023 51.55 Mn
Mar 31, 2023 57.13 Mn
Dec 31, 2022 60.19 Mn
Sep 30, 2022 117.66 Mn
Jun 30, 2022 108.98 Mn
Mar 31, 2022 143.64 Mn
Dec 31, 2021 351.41 Mn
Sep 30, 2021 368.76 Mn
API Access

Monte Rosa Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=GLUE&period=max&api_key=YOUR_API_KEY